Browman C P, Winslow D H
Sleep Disorders Center, Humana Hospital-Audubon, Louisville, Kentucky 40217.
Clin Electroencephalogr. 1989 Jan;20(1):45-8. doi: 10.1177/155005948902000110.
Sleep onset during the multiple sleep latency test was scored by three criteria for 21 patients with narcolepsy and 21 patients with obstructive sleep apnea: a single epoch of stage 1, three consecutive epochs of stage 1, and a single epoch of stage 2 or REM. Mean sleep latency for both groups was predictably shortest using a single epoch of stage 1 and longest using a single epoch of stage 2 or REM. All estimates of sleep latency were highly correlated. It was concluded that a single epoch of any stage of sleep is an appropriate measure of sleep latency for patients with narcolepsy, although a modified scoring system should be developed for patients with sleep apnea. The obstructive apneic episodes prevented or delayed sleep onset on 4.8% to 33.3% of trials depending on the specific criteria used to determine sleep latency. Such apnea-related interruptions to sleep should be taken into account when assessing daytime somnolence in patients with sleep apnea.
在多次睡眠潜伏期试验中,依据三个标准对21例发作性睡病患者和21例阻塞性睡眠呼吸暂停患者的入睡情况进行评分:一个1期睡眠片段、三个连续的1期睡眠片段以及一个2期或快速眼动(REM)睡眠片段。不出所料,两组患者使用一个1期睡眠片段时平均睡眠潜伏期最短,使用一个2期或REM睡眠片段时平均睡眠潜伏期最长。所有睡眠潜伏期的估计值都高度相关。得出的结论是,对于发作性睡病患者,任何一个睡眠阶段的单个片段都是衡量睡眠潜伏期的合适指标,不过对于睡眠呼吸暂停患者,应制定一个修改后的评分系统。根据用于确定睡眠潜伏期的具体标准,阻塞性呼吸暂停发作在4.8%至33.3%的试验中会阻止或延迟入睡。在评估睡眠呼吸暂停患者的日间嗜睡情况时,应考虑到这种与呼吸暂停相关的睡眠中断。